Amgen Faces Potential Lack Of Near-Commercial Assets

Company’s Q3 Call Likely To Focus On Pipeline, Not Sales

 
• By Mandy Jackson
  
Close-up Of Businessperson Checking Bills With Magnifying Glass
Amgen needs to fill revenue gaps with near-term commercial products
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Earnings

More from Business